Wallstreet123's Personal Finance Blog

The Greater China Fund, Inc. (NYSE:GCH) declared a dividend of $0.0444 per share of ordinary income. The dividend is payable on September 14, 2011 to shareholders of record as of September 7, 2011. The ex-dividend date is September 2, 2011. The Fund is a non-diversified, closed-end management investment company that seeks long-term capital appreciation through investing primarily in listed securities of China companies, which are companies that are organized under the laws of, and have their principal place of business in, China or Hong Kong or during their most recent fiscal year derived at least 50% of their revenues or profits from goods produced or sold, investments made or services performed in China or Hong Kong or have at least 50% of their assets in China or Hong Kong. There can be no assurance the Fund will achieve its objective. The Fund's investment adviser is Baring Asset Management (Asia) Limited.

Read more at: http://crwewallstreet.com/?p=21014

ITT Corporation (NYSE:ITT) has announced, in connection with filing amended Form 10 registration statements later today for its two company spinoffs, Xylem and ITT Exelis, that Markos Tambakeras will serve as non-executive chairman of the board of Xylem, the future independent water technology business. Mr. Tambakeras will assume this post when the spinoffs are completed.
Read more at: http://crwewallstreet.com/?p=21013

Crown Equity Holdings Inc. (CRWE)
Crown Equity Holdings Inc. (CRWE) is pleased to announce that it has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. Crown Equity Holdings Inc. will own fifty percent (50%) interest in the joint venture.
Read more at: http://crwewallstreet.com/?p=21012

Movado Group, Inc. (NYSE:MOV) invites investors to listen to a broadcast of the Company's conference call to discuss second quarter earnings results. The conference call will broadcast on Thursday, September 1, 2011 at 10:00 a.m. Eastern Time at www.movadogroup.com. This call will be archived online within one hour of the completion of the conference call. Additionally, a telephonic re-play of the call will be available through September 8, 2011 and can be accessed by dialing (858) 384-5517, passcode 3185478.
Read more at: http://crwewallstreet.com/?p=21011

Seattle Genetics has developed next generation ADCs that link the proven selectivity and activities of monoclonal antibodies with highly potent cytotoxic agents. Our proprietary technology employs synthetic, potent tumor cell-killing agents called auristatins (such as MMAE and MMAF) and stable linkers that attach the auristatin to the antibody. Our novel linker systems are designed to be stable in the bloodstream and release the potent cell-killing agent once inside targeted cancer cells. This approach is intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity.

Collaborating with leading biopharmaceutical companies is a cornerstone of Seattle Genetics’ business strategy. Product-focused collaborations, such as our collaboration agreement with Millennium: The Takeda Oncology Company to globally develop and commercialize brentuximab vedotin, provide significant near- and mid-term funding while bringing in additional resources and expertise to support, advance and expand promising development programs. Collaboration and license agreements around our proprietary ADC technology also generate cash for the company - more than $155 million to date - while providing further clinical validation of the ADC platform and, in some cases, opening the door to new product development opportunities.






Seattle Genetics, Inc. (Nasdaq:SGEN) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of ADCETRISTM (brentuximab vedotin) for two indications: (1) the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, and (2) the treatment of patients with systemic anaplastic large cell lymphoma (ALCL) after failure of at least one prior multi-agent chemotherapy regimen. The indications for ADCETRIS are based on response rate. There are no data available demonstrating improvement in patient-reported outcomes or survival with ADCETRIS. ADCETRIS is the first drug approved by the FDA for Hodgkin lymphoma in more than 30 years, and provides a new therapeutic alternative for Hodgkin lymphoma and systemic ALCL in these settings. Seattle Genetics expects to make ADCETRIS available to patients next week. ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30.

Seattle Genetics is a biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer. Seattle Genetics’ first product, ADCETRIS™, was approved by the FDA on August 19, 2011 for the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, and for the treatment of patients with systemic anaplastic large cell lymphoma (ALCL) after failure of at least one prior multi-agent chemotherapy regimen. In addition to ADCETRIS, Seattle Genetics has three other clinical-stage programs: SGN-75, ASG-5ME and ASG-22ME. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Abbott, Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, Millennium, Pfizer and Progenics, as well as ADC co-development agreements with Agensys, an affiliate of Astellas, and Genmab.

More information can be found at www.seattlegenetics.com.

Read more at: http://crwewallstreet.com/?p=21002

United Community Financial Corp. (Nasdaq:UCFC) reported a consolidated net loss of $1.8 million, or $(0.06) per diluted share, for the three months ended June 30, 2011. This compares to a net loss of $4.9 million, or $(0.16) per diluted share, for the three months ended June 30, 2010. The Company also reported cumulative net income of $1.2 million, or $0.04 per diluted share, for the six months ended June 30, 2011, as compared to a cumulative net loss of $10.0 million, or $(0.33) per diluted share, for the six months ended June 30, 2010.
Read more at: http://crwewallstreet.com/?p=21000

National Interstate Corporation (Nasdaq:NATL) announced that its Board of Directors approved a $0.09 per share dividend payable on September 12, 2011 to shareholders of record of the Company’s common stock as of the close of business on August 29, 2011. The Company has paid a dividend each quarter since the 2005 fourth quarter and increased it annually during the first quarter each year beginning in 2006.
Read more at: http://crwewallstreet.com/?p=21001

Global Education & Technology Group Limited (Nasdaq:GEDU) announced that it plans to release its unaudited second quarter 2011 financial results on August 29, 2011, after the market closes. The Company will hold a conference call at 8:00 p.m. U.S. Eastern Time on Monday, August 29, 2011. The Company will hold a conference call at 8:00 p.m. U.S. Eastern Time on Monday, August 29, 2011 (8:00 a.m. Beijing Time on August 30, 2011) to discuss its unaudited second quarter 2011 financial results. Listeners may access the call by dialing: US Toll Free: +1-800-860-2442, International: +1-412-858-4600, Access code: Global Education & Technology.
Read more at: http://crwewallstreet.com/?p=20995

Unilife Corporation (NASDAQ:UNIS) announced that its Chief Executive Officer, Alan Shortall, intends to purchase U.S. $500,000 in shares of the Company’s common stock over the next week. Mr. Shortall intends to begin purchasing these shares this week at market prices forty-eight hours after the issuance of this release in the U.S. Furthermore, Mr. Shortall has advised the Board of Directors of Unilife that he intends to purchase up to an additional U.S. $500,000 of the Company’s common stock between now and September 30, 2011. Mr. Shortall intends to provide twenty-four hours advance notice to U.S. markets before purchasing these additional Unilife shares.
Read more at: http://crwewallstreet.com/?p=20996

Crown Equity Holdings Inc. (CRWE)
Voice over Internet Protocol or VOIP is a way of making telephone conversations using the Internet. Some of us still remember the days when one had to book long distance calls through operators.
Direct dialing became a reality towards the end of the last century, but even bypassing a switchboard and a telephone exchange, does not match the savings and convenience of using VOIP.
Combining of cellular telephones and the Internet have potentials for further breakthroughs as far as VOIP is concerned.
Read more at: http://crwewallstreet.com/?p=20997

Cleantech Transit Inc (CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech Transit Inc has expanded its focus to invest directly in specific green projects that could maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech Transit Inc. has selected to invest in Phoenix Energy (www.phoenixenergy.net).
Read more at: http://crwewallstreet.com/?p=20994

Caterpillar Inc. (NYSE:CAT) announced that Gary Stroup, 62, has elected to retire following a distinguished career of more than 39 years with the company. Stroup has been a Caterpillar vice president since 1992, and currently has responsibility for the Large Power Systems Division. A replacement for Stroup will be named prior to the end of the year.
Read more at: http://crwewallstreet.com/?p=20985

Crown Equity Holdings Inc. (CRWE)
Benefits of Online Marketing:
o Cost Effective way for marketing your organization products and services
o Improves the Online Visibility of your web site on search engines and social media platform with effective Search Engine Optimization, Paid Search Optimization (Pay per Click Management) and Social Media Optimization techniques
o Makes your products and services reach the targeted audience (local or global)
o Increases the time spent by visitors on your web site and thereby reduce bounce rate factor
o Enhance the conversion rate (visitor to customer conversion) using website sales optimization or sales conversion optimization techniques
o Maximizes the ROI (Return of Investment) Rate
Read more at: http://crwewallstreet.com/?p=20984

Seaspan Corporation (NYSE:SSW) announced that it accepted delivery of a 13100 TEU containership, the COSCO Development, on August 10, 2011. The new containership, which was constructed by Hyundai Heavy Industries Co., Ltd., is Seaspan's ninth delivery in 2011 and expands the Company's operating fleet to 64 vessels. The COSCO Development is on charter to COSCO Container Lines Co., Ltd. ("COSCON") under a twelve-year, fixed-rate time charter. The ship is the third of eight 13100 TEU sister ships and the 13th of a total of 18 vessels to be chartered by Seaspan to COSCON.
Read more at: http://crwewallstreet.com/?p=20983

Horizon Lines, Inc. (NYSE:HRZ) announced that Alherd Kazura has been appointed to the new position of Vice President of International Services. Mr. Kazura will report to Brian Taylor, Executive Vice President, Chief Operating Officer and Chief Commercial Officer of Horizon Lines, Inc. Mr. Kazura was previously Vice President International Planning and Development at Horizon, where among other responsibilities he led the transition team that established the carrier's Five Star Express (FSX) trans-Pacific service in December 2010. As VP of International Services, Mr. Kazura will take overall responsibility for the FSX service, which calls Shanghai, Ningbo, Los Angeles, Oakland and Apra Harbor, Guam.
Read more at: http://crwewallstreet.com/?p=20982

The Gabelli Equity Trust Inc. (NYSE:GAB) declared a $0.14 per share cash distribution payable on September 23, 2011 to common stock shareholders of record on September 16, 2011. The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Directors. Under the Fund's current distribution policy, the Fund intends to pay a minimum annual distribution of 10% of the average net asset value of the Fund within a calendar year or an amount sufficient to satisfy the minimum distribution requirements of the Internal Revenue Code, whichever is greater.
Read more at: http://crwewallstreet.com/?p=20981

EnerSys (NYSE:ENS) announced that its Board of Directors unanimously approved on August 12, 2011 the repurchase of up to $50 million of its common stock. The authorized repurchases will be made from time to time in either the open market or through privately negotiated transactions. The timing, volume and nature of share repurchases will be at the sole discretion of management, dependent on market conditions, applicable securities laws, and other factors, and may be suspended or discontinued at any time. No assurance can be given that any particular amount of common stock will be repurchased.
Read more at: http://crwewallstreet.com/?p=20980

Cleantech Transit Inc (CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech Transit Inc has expanded its focus to invest directly in specific green projects that could maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech Transit Inc. has selected to invest in Phoenix Energy (www.phoenixenergy.net).
Read more at: http://crwewallstreet.com/?p=20979

Piedmont Office Realty Trust, Inc. (NYSE:PDM) announced its results for the quarter ended June 30, 2011. Achieved Funds From Operations ("FFO") of $0.38 per diluted share; Completed approximately 1.2 million square feet of leasing at the Company`s 79 consolidated office properties, including 741,000 square feet of renewal leases and 439,000 square feet of new leases; Purchased The Dupree, a 138,000 square foot building located in Atlanta`s Northwest submarket and The Medici, a 152,000 square-foot building located at 3284 Northside Parkway NW in the Piazza at Paces mixed-use development complex in Atlanta`s Buckhead submarket.
Read more at: http://crwewallstreet.com/?p=20978

Cleantech Transit Inc (CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech Transit Inc has expanded its focus to invest directly in specific green projects that could maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech Transit Inc. has selected to invest in Phoenix Energy (www.phoenixenergy.net).
Read more at: http://crwewallstreet.com/?p=20977

Crown Equity Holdings Inc. (CRWE)
Crown Equity Holdings Inc. (CRWE) is pleased to announce that it has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. Crown Equity Holdings Inc. will own fifty percent (50%) interest in the joint venture.
Read more at: http://crwewallstreet.com/?p=20976

Founded in 1991, Albany Molecular Research, Inc. provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world’s leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the United States., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.

AMRI (NASDAQ:AMRI) announced it received a federal contract award from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) to provide chemistry and other drug discovery technologies in support of NINDS’ Medicinal Chemistry for Neurotherapeutics Program (MCNP), part of the NIH Blueprint Neurotherapeutics Network. AMRI has been collaborating with NINDS since 2005 on novel treatments for spinal muscular atrophy, a degenerative neuromuscular disease.
The five-year contract provides AMRI with funding of up to $43 million, based on the number of approved projects and availability of funds. The initial funding of up to $10 million applies to the first phase of the project, expected to begin this month, with the objective of delivering at least one Phase I clinical trial candidate.
Under the MCNP, AMRI will begin providing medicinal chemistry services to neuroscientists throughout the United States with the goal of efficiently developing pre-clinical drug candidates that are suitable for advanced development and ultimately clinical trials in humans. AMRI will utilize its integrated drug discovery capabilities involving exploratory chemistry, hit-to-lead chemistry, and lead optimization. Specific services to be provided include compound design, synthesis, and management together with in vitro metabolic testing.
More about AMRI at www.albmolecular.com
Read more at: http://crwewallstreet.com/?p=20975

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced that its Board of Directors, after consultation with its legal and financial advisors, has unanimously determined that the previously disclosed proposal by MSMB Capital is not reasonably expected to result in a superior offer to the merger with Allos Therapeutics, Inc. Therefore, the AMAG Board of Directors unanimously opposes MSMB Capital’s proposal and reaffirms its prior determination that the merger agreement with Allos Therapeutics, Inc. and the merger contemplated thereby are advisable and fair to, and in the best interests of, AMAG and its stockholders.
Read more at: http://crwewallstreet.com/?p=20965

Crown Equity Holdings Inc. (CRWE)
VoIP (Voice over Internet Protocol) is the latest phone system technology. VoIP phone systems convert regular telephone calls into digital data delivering the voice communications over the Internet, or a packet-switched network. Essentially, when using a VoIP system, you are using the Internet to make telephone calls as opposed to a traditional phone line.
Read more at: http://crwewallstreet.com/?p=20966

Rand Logistics, Inc. (Nasdaq:RLOG) announced financial and operating results for its fiscal year 2012 first quarter ended June 30, 2011. Marine freight revenue (excluding fuel and other surcharges, and outside charter revenue) was $30.7 million, an increase of 8.1% from $28.4 million. The increase in marine freight revenue was attributable to a 4.1% increase in the number of days sailed, contractual price increases, new business and an increase in the average size of our vessels operating due to our February 2011 acquisition of two vessels.
Read more at: http://crwewallstreet.com/?p=20967

DENTSPLY International Inc. (Nasdaq:XRAY) announced that it has priced an offering of the following debt securities (”Securities”): $250 million in aggregate principal amount of floating rate senior notes due 2013; $300 million in aggregate principal amount of 2.75% senior notes due 2016; and $450 million in aggregate principal amount of 4.125% senior notes due 2021. Closing of the offering is expected to take place on August 23, 2011.
Read more at: http://crwewallstreet.com/?p=20968

Handy & Harman Ltd. (NASDAQ:HNH) reported financial results for the second quarter and six months ended June 30, 2011. HNH reported net income of $16.8 million on net sales of $191.2 million for the three months ended June 30, 2011, compared with net income of $6.3 million on net sales of $160.9 million for the three months ended June 30, 2010. Basic and diluted net income per common share was $1.32 for the three months ended June 30, 2011, compared with $0.52 per share in the same period of 2010. Net income for the 2011 quarter includes unrealized non-cash $3.7 million gain on embedded derivatives related to the Company’s subordinated notes and warrants.
Read more at: http://crwewallstreet.com/?p=20970

TeamStaff, Inc. (Nasdaq:TSTF) announced that it is to share in the award of a TACOM Omnibus III contract, from the U.S. Army`s Program Executive Office for Combat Support & Combat Service Support (PEO CS&CSS) in Warren, Michigan as a member of the O`Neil and Associates (ONEIL) team. The total contract value is $225 million and runs through 2012, with 16 contractor teams now eligible to compete for individual service tasks under this contract. No assurances can be given as to the amount of revenues that the Company will receive as a result of this contract.
Read more at: http://crwewallstreet.com/?p=20971

LightPath Technologies, Inc. (NASDAQ:LPTH) announced its preliminary financial results for the fourth quarter ended June 30, 2011. The Company reported preliminary revenue of $2.78 million for the fourth quarter of fiscal 2011, a decrease of 1%, as compared to $2.81 million for the same period last year and an increase of 14% as compared to the third quarter of fiscal 2011. Full year revenue for fiscal 2011 grew 8% to $10 million as compared to $9.2 million for fiscal year 2010.
Read more at: http://crwewallstreet.com/?p=20972

Crown Equity Holdings Inc. (CRWE)
Crown Equity Holdings Inc. (CRWE) is pleased to announce that it has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. Crown Equity Holdings Inc. will own fifty percent (50%) interest in the joint venture.
Read more at: http://crwewallstreet.com/?p=20973